U.S. market Closed. Opens in 9 hours 57 minutes

CTKB | Cytek Biosciences, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 5.09 - 5.34
52 Week Range 3.80 - 9.87
Beta 1.32
Implied Volatility 240.31%
IV Rank 53.88%
Day's Volume 673,259
Average Volume 605,395
Shares Outstanding 131,506,000
Market Cap 683,831,200
Sector Healthcare
Industry Medical - Devices
IPO Date 2021-07-23
Valuation
Profitability
Growth
Health
P/E Ratio -37.14
Forward P/E Ratio N/A
EPS -0.14
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 645
Country USA
Website CTKB
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The company also provides reagents and kits, including cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, which are automated plate loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
*Chart delayed
Analyzing fundamentals for CTKB we got that it has weak fundamentals where Valuation is considered to be overvalued, Profitability is unacceptably poor, Growth is very bad and Health is passable. For more detailed analysis please see CTKB Fundamentals page.

Watching at CTKB technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, but short-term trend is bullish. More technicals details can be found on CTKB Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙